BRUSSELS (Reuters) - AstraZeneca must provide reassurance that it will not profit from its potential COVID-19 vaccine, non-governmental organisation Medecins Sans Frontieres (MSF) said on Tuesday, urging the company to make public its supply contracts. The British firm said on Monday its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, giving the world's fight against the global pandemic a third new weapon that can be cheaper to make, easier to distribute and faster to scale-up than rivals. AstraZeneca has said it will not profit from sales ...
AstraZeneca must prove it won't profit from Covid-19 vaccine: Non-govt body
The price of its candidate has been set at about $3 per dose, against at least four times more for other candidates